On April 8, 2026, Beneficient reported a primary capital transaction involving funding of a limited partner interest valued at $8.75 million, resulting in them acquiring 875,214 shares of Series B-10 Preferred Stock. This transaction allows Beneficient to participate in a potential unrealized gain of approximately $1.2 million.